substance p has been researched along with Coronary Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chia, S; Fox, KA; Ludlam, CA; Megson, IL; Newby, DE | 1 |
| Boon, NA; Flint, L; Fox, KA; Ludlam, CA; McLeod, AL; Newby, DE; Uren, NG; Webb, DJ | 1 |
1 trial(s) available for substance p and Coronary Thrombosis
| Article | Year |
|---|---|
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
Topics: Area Under Curve; Blood Flow Velocity; Cardiac Catheterization; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Coronary Vessels; Endosonography; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Smoking; Substance P; Tissue Plasminogen Activator; Vasodilator Agents | 2001 |
1 other study(ies) available for substance p and Coronary Thrombosis
| Article | Year |
|---|---|
Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.
Topics: Acetylcholine; Aged; Case-Control Studies; Coronary Restenosis; Coronary Thrombosis; Endothelium, Vascular; Female; Fibrinolysis; Humans; Male; Middle Aged; Nitroprusside; Platelet Aggregation; Regional Blood Flow; Stents; Substance P | 2003 |